title: Overcoming pharmacokinetic problems in the treatment of Parkinson's disease.
authors.affiliation: Department of Neurology, Clinica Universitaria-Medical School, University of Navarra, Pamplona, Spain.
authors.forename: J A
authors.initials: JA
authors.lastname: Obeso
authors.forename: J
authors.initials: J
authors.lastname: Vaamonde
authors.forename: F
authors.initials: F
authors.lastname: Grandas
authors.forename: M R
authors.initials: MR
authors.lastname: Luquin
authors.forename: M
authors.initials: M
authors.lastname: Rodriguez
authors.forename: G
authors.initials: G
authors.lastname: Lera
authors.forename: J M
authors.initials: JM
authors.lastname: Martínez-Lage
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007980:Levodopa / Q000493:pharmacokinetics; D010300:Parkinson Disease / Q000097:blood* / Q000188:drug therapy; D011954:Receptors, Dopamine / Q000187:drug effects
chemical_list: D000978:Antiparkinson Agents; D011954:Receptors, Dopamine; D007980:Levodopa